Business
Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products
Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based...
About this update from Pond Technologies Holdings Inc.
[{"type":"text","content":"\n\n\n\nPond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em\n}\n\n\n\n\n\n\n\nCanada NewsWire\nCALGARY, Oct. 17, 2019\n\n\n\nCALGARY, Oct. 17, 2019 /CNW/ - Pond Technologies Holdings Inc. (\"Pond\") (TSX.V: POND) is pleased to announce that Pond Naturals, its wholly owned subsidiary, is expanding the distribution of its astaxanthin-based pet supplement to the US. Pond Naturals has entered a three-year license agreement with Applied BioSciences (\"Applied Bio\") https://appliedbiocorp.com/ to sell its X10-branded pet products through Applied Bio's online sales channels.\nNevada based Applied Bio develops and markets CBD-based therapeutics and biopharmaceuticals through established channels in the US, including its premium pet brand, Herbal Pet. Applied Bio intends to sell X10 products alongside Herbal Pet products through its existing e-commerce channels. \nHerbal Pet has developed a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion (www.HerbalPet.com). X10 is a great complementary product to Herbal Pet as it contains nature's most powerful antioxidant: astaxanthin ('asta-zan-thin'), extracted from algae at Pond Natural's Agassiz, British Columbia facility (www.X10Pet.com). \nLike Herbal Pet, X10 targets the premium pet segment, using only natural and vegan ingredients.  \nLondon, UK based research firm, Technavio, estimates that the global pet dietary supplements market will grow by US$624 Million through 2023, or at a 5% CAGR. It identifies the launch of high quality pet dietary supplements as a key driver of this growth. \nChris Bridges, Applied Bio President, stated,\n\"We are excited to introduce X10 to our loyal customer base as a great complementary product to Herbal Pet's CBD line. While CBD can act quickly in the body, astaxanthin provides long-term relief from chronic conditions, making for an intriguing one-two punch of natural health products. Adding X10 t...